Related Experiment Video
Updated: Aug 16, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
A new recombinant virus system for the study of HIV-1 entry and inhibition
Francois Roman1, Wim Ammerlaan, Jean-Marc Plesseria
1Retrovirology Laboratory, Centre de Recherche-Public (CRP)-Santé, 84 rue Val Fleuri, L-1526 Luxembourg, Luxembourg. roman.f@retrovirology.lu
Abstract:
The construction is described of a HIV-1 proviral, eGFP-tagged plasmid that allows for the recombination of any selected env gene without the use of restriction enzymes and for the quantitation of the infection by the recombinant virus using flow cytometry. The system was tested showing that an isoleucine to valine substitution at residue position 37 of the HIV-1 gp41 impairs the fitness of the virus but does not lead by itself to T-20 resistance.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles

